Supriya Lifescience Ltd - Prospectus Synopsis

Supriya Lifescience Ltd RHP

Registered Office : 207/208 Udyog Bhavan , Sonawala Road Goregaon (East) , Mumbai - 400063 , Maharashtra , India.

Phone : 91-22-40332727 Fax :

Email :cs@supriyalifescience.com Website : www.supriyalifescience.com

Initial public offering of 25,547,445* equity shares of face value of Rs. 2 each (Equity Shares) of Supriya Lifescience Limited (The Company or the Issuer) for cash at a price of Rs. 274 per equity share (Offer Price) aggregating to Rs. 700.00 crores, comprising a fresh issue of 7,299,270* equity shares aggregating to Rs. 200.00 crores (Fresh Issue) and an offer for sale of 18,248,175* equity shares aggregating to Rs. 500.00 crores by Satish Waman Wagh (The Promoter Selling Shareholder) (The Offer for Sale, together with the fresh issue, the Offer). The offer will constitute 31.74% of the post-offer paid-up equity share capital. *Subject to finalisation of basis of allotment The face value of each equity share is Rs. 2 each. The offer price is 137 times the face value of the equity shares. Bids can be made for a minimum of 54 equity shares and in multiples of 54 equity shares thereafter.

Issue		Money Payable On
Opens On	Closes On	Application	Allotment
12/16/2021 12:00:00 AM	12/20/2021 12:00:00 AM	Rs 274 - 0	Rs 0 - 0
Minimum Application for shares in Nos : 54 Further Multiples of : 54

	Rs Cr	Lead Managers to the Issue
Project Cost	200	Axis Capital Ltd
Project Financed through Current Offer	700
Post Issue Equity Share Capital	200
Issue Price	Rs. 274

Projects
Funding Capital Expenditure Requirements of the Company

Promoted By

Listing At

Registrar to the Issue

Satish Waman Wagh

Link Intime India Pvt Ltd

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

ATTENTION INVESTORS

Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Risk Disclosure on Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to Rs. 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

We are ISO 27001:2013 Certified.

This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.

Supriya Lifescience Ltd - Prospectus Synopsis

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.

MARKET

IDEAS

MUTUAL FUNDS

TRADING DOCUMENTATION

CALCULATOR

GLOSSARY (A-Z)

ATTENTION INVESTORS

Risk Disclosure on Derivatives

We are ISO 27001:2013 Certified.